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n8081 CorrelationBetweenOxidizedLowDensityLipoproteinsendCoronaryAtieryDiseasein Heart
TransplantPatienta
J. Vanhaecke, J.-M. Stassen, J. Van Cleemput, D. Cohen, P.Holvoet.
University of Leuven, Leuven, Belgium
The hypothesis that oxidized low density lipoproteins (OXLDL) play a role
in the pethogenesis of coronay artery disease in heart transplant patients
wae investigated. OXLDLwere measured with a monoclinal antibody (mAb-
4E6) based enzyme linked immunoeorbant assay (ELISA) that discriminated
OXLOL and native LDL 1000-fold. Blood samples were collected from 107
heart transplant patients, between 12 and 64 months affersurgery, and coro-
nary attery stenosis in these patients was assessed bycorona~ angiography.
Mean levels of OXLDL were significantly lower in patienta with angiograph-
icdly normal mronary arteries (grade O: 1.2 + 0.05 mg/dl; n = 79) than in
patients with mild (grade 1:2.1 +0.30 mg/dl; n = 18, p <0.001 vs grade O)or
severe (grade 11:3.2 +0.45 m@dl;n = 10; p < O.COIvs grade Oand p <0.05
vs grade 1)coronaty artery stenosis. Logistic regression analysis identified 4
(out of 18) parameters that were significantly and independently correlated
with poettransplant coronaty artery stenosis: plasma levels of OXLDL (p =
0.0001), length of follow-up (p = 0.0008), cytomegalovirus infection (p =
0.015) and donor age (p= 0.047). Coronary artery disease developed in 12
of 46 heart transplantation patients during a 3years follow-up period. Logistic
regression analysis revealed that plasma levels of OXLDL (p = 0.0076) and
age of donor (p= 0.035) predicted the progression of Coronav artery steno-
sis in these patienta. Conclusion: Plasma levels of OXLDLcorrelate with the
extent and the progression of posttrensplant coronary artery stenosis in heart
transplant patients.
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n8082 DonorHeartIachemicTimeiaa RiakFactorfor EarlyManifeatstionofAllograftCoronaryArtaryDisease
M. Nishimura, B. Radovancevic, W. Springer, E.K. Massin, O.H. Frazier.
TexasHearf Institute, Houston TX, USA
To test the hypothesis that early manifestation of ACAD is related to poorer
prognosis, we determined the mortality rates and dsk factors in patients
in whom ACAD was detected at 3 yeara or before (early ACAD) and at 3
yeara and after (late ACAD). Patients who underwent cardiac transplantation
between 1966 and 1990 (n = 110) were monitored with yearly coronav
arteriograms. The mean follow-up period was 73 months (13-116 months).
At 3 yeara after transplantation, 47 of 110 patients were diagnosed with
ACAD, and between 3 and 6 yeara after transplantation, an additional 22
patients were diagnosed with ACAD. The rate of mortality or graft loss from
ACAD at 2 yeara after diagnosis wee 57Y0for early ACAD and 16% for late
ACAD (p < 0.05). Multivariate analysis wasappliadtofactors associated with
the development of ACAD. The variables were: number of rejection episodes,
CMV infection, hyperlipidemia, diabetes mellitus, recipient age, donor age,
and donor iachemic time. The only significant predictor for the development
of early ACAD was a donor heart ischemic time longer than 160 min (p <
0.05), whereas the development of late ACAD was better predicted by other
factors, such as CMV infection, postoperative diabetes mellitus, and older
age of recipient. These data suggest that early ACAD is associated with a
higher mortality or graft loss rate and, further, that a donor heart with a long
ischemic time (>180 rein) is more likely to develop early ACAD. It appears
that ischemic injury plays a major role in development of early ACAD; thus
improvement in organ preservation and efforts to shorten the ischemic time
may provide additional protection for the development of early ACAD.
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n8083 BloodTroponin-TConcentratiOneCOrralStewithCoronaryArteryDiaeasesndAbnormslHemosteais,
FibrinolyaieandEndothelialActivationincardiac
AllogrstiRecipient
W.P. Faulk, R.J. Terry,C.A. Lsbarrere, D.R. Nelson, R.J. Kovacs,
Department of Research, Methodist Hospital, Indianapolis, Indiana, USA
Ourpublishad data from endomyoeardial biopsies haveshown that transplant-
induced coronaty artery disease (T-CAD) is preceded by these changes in
myocardial arteries and arterioles: (a) fibrin deposition, (b) depletion of tis-
sue plasminogen activator (tPA), and (c) endothelial activation. Although
these findings predict T-CAD, they require multiple biopsies. We have sought
serologic markers that predict T-CAD, similar to those that predict a risk for
spontaneous CAD. Unfortunately, biochemical risk factors for spontaneous
CAO do not apply to patients at risk for T-CAD. Our studies have focused
on serum concentrations of troponin-T (TnT), which measure the occurrence
and severity of myocardial infarctions. We asked if transplant recipients who
develop T-CAD have increased blood concentrations of TnT, and if these
concentrations correlate with biopsy findings of fibrin deposition, tPA deple-
tion and endothelial activation. We analyzed immunocyfochemical data from
111biopsies and multiple sample analysis of variance for TnTconcentrations
of 111 sera obtained at the time of biopsy from 46 allografl recipients. All
patients had coronary angiography. These experiments revealed highly sig-
nificant correlations of TnT with fibrin deposits (p = 0.001), tPAdepletion (p =
0.001), activation of atteriolar endothelium (p = 0.001), and CAD (p = 0.01).
Correlation with infiltrates of T-lymphocytes was not significant (p = 0.9). We
conclude that transplant recipients with elevated serum TnT concentrations
are at high risk for having T-CAD.
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H Tri9;YcerideLavelsCorrelstawithMicrovsac.larBut
NotEpicardialEndothelialDysfunctionAftarHeart
Tranaplantstion
S.M. Hollenberg, D. Bums, P.Tamburro, MR. Johnson, C. Easington,
M.R. Costanzo, J.E. Parrillo, L.W. Klein. Rush Medical College, Chicago, IL,
USA
Background: Endothelial dysfunction may represent an early marker forcoro-
nary allografl vasculopathy (CAV) following heart transplantation (TX). Lipid
levels correlate with endothelial dysfunction in native coronary arteries, and
triglyceride (TG) Ievelscorrelate with intimal thickening in TXpatients, but the
relationship between TG levels, endothelial dysfunction, and CAV following
TX has not been elucidated. Methods.’We used simultaneous intravascular
ultrasound (IVUS) and Doppler flow studies to distinguish epicardial from
microvascular endotheiial dysfunction find correlated dysfunction with lipid
levels. Diameter (IVUS) and velocity (Doppler wire) responses to intracoro-
nary adenosine (ADEN, 32 &g bolus) and acetylcholine (ACH, 54 #g over
2 rein) were evaluated in the LAD of 23 patients with normal coronary an-
giograms >1 yr after TX. Fasting lipid profiles were obtained at the time of
the study. Results: ACH induced vasodilation in 15 patients and paradoxical
vasoconstriction in 6. Epicardial area responses to ACH did not correlate with
lipid levels, but microvascular flow responses to ACH correlated negatively
with TG levels (r = 0.56, p = 0.01). When ACH flow responses were nor-
malized to ADEN responses, a significant correlation with TG levels was still
found (r= 0.50, p =0.03). Conclusions: Microvascular, but not epicardial, en-
dothelial dysfunction correlated with TG levels. These findings suggest that
lipids play a greater role in microvascular than epicardial endothelial dys-
function in CAV following heart transplantation, and reinforce the importance
of rigorous lipid control in thesepatients.
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~~ MechsnoenergeticEffectaof EMD~~~~~”nder
NormalandAcidoticConditionsin Isolated,Blood
PerfusedRabbitHssrts
T. Kameyama, Z. Chen, M.W. Watkins, M.M. LeWinter. The Univereifyof
Vermont,Burlington, ~ USA
Ca2+ sensitizing drugs may have reduced energy costs compared to con-
ventional agents and might be especially effective during acidosis when
myofilament Ca2+ desensitization occurs. We compared the effects of EMD
57033 (EMD), relatively selective Ca2+sensitizer, and dobutamine (OO@on
mechanoenergetics in an isovolumically contracting, rabbit heart preparation
under conditions of normal pH and acidosis. Myocardial 02 consumption
(VQ), the slope of the end-systolic pressure-volume relation (E~a.), force-
time integral (FTI) and pressure-volume area (PVA) were measured. l/slope
of the V02-PVA relation reflects the energy conversion efficiency (EFF) of
the contraefile machine~ and its V02 intercept (lNT) is a measure of non-
mechanical 02 consumption. At doses resulting in similar increases in E~m
(23-24%), EMD and DOB cause disparate effects on relaxation half-time
(30% increase with EMO vs 22% decrease with DOB) but similar effects on
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the V02-PVA relation (59%. increase in INT with EMD vs 44% with DOB;
neither drug altered EFF) with normal PH.Acidosis decreased E~8Xby 22%,
increased INT by 14%, but did not change EFF [43 & 12 (SD) vs 38 +
13]. During acidosis, coronary flow increased (69%) with EMD, but was un-
changed with DOB. Compared to DOB, EMD resulted in greater increases
in both Emu (73Y0vs 24X.) and INT (I09Y0 vs 18%) but neither drug altered
EFF.Incontrast, contractile economy (l/slope of FTI-V02 relation) increased
(49%) with EMD but decreased (14%) with DOB with both normal pH and
acidosis. Conclusion: EMD is a more potent inotropic drug than DOB dur-
ing acidosis. In terms of contractile EFF, EMD does not have an energetic
advantage over DOB. However, its effects are more economical.
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809-2 The Ne+-Channel-Modulatora BDF 9148 and DPI
201-108 Exert Poaitive Inotropic Effect Without
Direct Interaction With the Contractile Proteina on
Human Myocardium
K. Brixius, C. Zobel, J. Muller-Ehmsen, H. Reuter, M. Pietsch, K. Frank,
R.H.G. Schwinger. K/inik/// furktnere Medizin, KWr, Germany
Only in right ventricular myooardium from patients with dilated cardiomyopa-
thy, but not from nonfailing patients, a Ca2+-sensitizing effect of DPI 201-106
has been described (J Clin Invest (1988) 82: 1578). The present study in-
vestigated the effect of the Na+-channel-modulators BDF 9148 (BDF, 1 MM)
and DPI 201-106 (DPI, 1 KM) on the Ca2+-sensitivity of chemically skinned
(Triton X, 1%, 20 h, 4’C) left ventricular muscle fibers (SFB) from patients
with dilated cardiomyopathy (DCM, n =8) and nonfailing patients (NF,n = 7).
For comparison, the Caz+-sensitizer EMD 57033 (EMD, 10 KM) was studied
as well.
In electrically stimulated left ventricular papillary muacle strips (1.6 mM
Ca2+, 1 Hz) from NF end DCM BDF, DPI and EMD significantly increased
force”of coritraction. In SFB EMD shifted the concentra~icm-responeecuwe
significantly to the left in DCM (95% confidential interval of EC50(Cl ECW):
control: 2.0-2.4 wM; +EMD: 0.5-1.0 PM) and NF (Cl EC50:2.6-3.5; +EMD:
0.4-0.7 PM). BDF and DPI did not influence the Caz+-sensitivity of the
contractile proteins towards Ca2+ in DCM and in nonfailing myocardium.
It is concluded, that (1) Caz+-sensitizere increase the sensitivity of the
contractile proteins towards Ca2+ in DCM and in nonfailing myocardium; (2)
BDF 9146 and DPI 201-106 increase force of contraction without increasing
the Ca2+-sensitivity of the contractile apparatus in man.
4:30
r8fJ9-3] hlechanimaofthe,~~-l poaitive,onotropic~ction
A. Cittadini, M. Spindler, H. Stromer, Y. Ishiguro, K.E. Travers, J.S. Ingwall,
J.P. Morgan. Harvard Medical School, Boston, MA, USA
Although chronic treatment with insulin-like growth factor-1 (IGF-1) is known
to increase cardiac function in humans and rats, its acute cardiac effects
and mechanisms of atiion are largely obacure. IGF-I was acutely admin-
istered in isovolumic buffer-perfused whole hearl preparations monitoring
functional indexes, and peak intracellular calcium levels, [Ca2+]i,with the ae-
quorin bioluminescence method. Ca2+ responsiveness of the myofilaments
was assessed by determining the maximal Ca2+activated pressure (MCAP)
and the ECW of the peak Ca2+-peak LV pressure relationship. 3’P NMR
spectroscopy was used to assess intracellular pH, [pH]i, and high energy
phosphate metabolism. The maximal positive inotropic effect of IGF-1, ob-
served ataconcentration of 10-7, was evident within 60s after the application
and persisted after its removal from the perfusate.
Data are mean 4 SE; DP = developed pressure; *p c 0.01 vs. baseline.
DP [Ca2+]j MCAP ECSO [PH]i
mmHg pmo!JL mmHg fimollL pH units
aaeeline 124 &4 0.76 k 0.01 173 *8 0.68 + 0.02 7.15 * 0,01
IGF-1 150+ 3* 0.74+ O.01* 215+5* 0.66+ 0.02 7.15+ 0.01
IGF-I increased DP by 21% from baseline. This positive inotropic effect
was mediated by an increase in myofilaments Ca2+ responsiveness, in
particular by an increase in MCAP since [Ca2+]t decreased. [pH]i and high
energy phosphate content did not change during IGF-1 infusion. IGF-I is a
drug with unique properties, acting primarily by sensitizing the myofilaments
to Ca2+without modifying high energy phosphate metabolism.
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LY366634, a Novel Sodium Channel Activator,
Improves Left Ventricular Function in Dogs With
Chronic Heart Failure
M. Tanimure, S. Shevlyagin, H. Shimoyama, Ml. Steinberg 1, S. Borzak,
S. Goldstein, H.N. Sabbah. Henry Ford Hear?end Vascu/ar/nstitute, Detroit,
Ml, USA, 1Lily Research Laboratories, Indianapolis, IN, USA
The hemodynamic effects of LY386634 (LY) (chemical name: (s)-4-[3-[[l-(di-
phenylmethyl)-3-azetidinyl]oxy]-2-hydroxypropoxy]-lh-indole-2-carbonitrile},
were examined in 7 dogs with chronic heart failure (HF) (LV ejection fraction
26+ 2%) produced by sequential intracoronary microembolizations. LY was
administered intravenously in incremental doses of 3, 5 and 10 @lg/min.
Each dose was administered for30 min. Heart rate (HR, rein-l), QTc interval
(msec), peak LV +dP/dt (mmHg/see) and LV fractional area of shortening
(FAS, %) were measured at baseline and at 30 minutes after the adminis-
tration of each of the 3 drug doses. FAS was meaaured from 2-D short axis
echocsrdiogrems.
Baaeline 3 @kgrmin 5 pglkglmin 10 z@lrg/mln
HR 82& 6 70’+ 6* 75* 7 70* 5
QTc 311*9 309* 7 325* 11 339* 17*
+dP/dt 1569+ 118 1929* 137” 2146+ 116* 2388+ 155*
LVFAS 27& 2 32k 2* 37* 2* 43+ 2*
*P <0.05 va, Baseline,ANOVA withStudents-Newman-Keulsteat
LY was not associated with ventricular arrhythmias. It tended to reduce
HR and had no effect on QTc interval except at the highest dose used. In
addition, LY significantly improved peak LV +dP/dt and FAS. Conclusion: in
dogs with HF,intravenous LYimproves LVsystolicfunction without increasing
HR and with little or no prolongation of QTc interval. These findings suggeat
that LY may be a useful agent for the ehort-term treatment of patients with
advanced HF.
u810 Cardiac Arrest and Emergency Care
Wednesday, March 19, 1997, 4:00 p.rn.-5:O0 p.m.
Anaheim Convention Center, Room C2
4:00
El8101 Post-Reauscitetion Left Ventricular Diastolic
Dysfunction Successfully Treated with Dobutemine
K.B. Kern, R.W. Hilwig, R.A. Berg, K.H. Rhee, A.B. Sanders, C.W. Otto,
G.A. Ewy. The UniversifyofArizona, Tucson,Arizone, USA
Significant left ventricular dysfunction, including both eystolic and diastolic,
has been documented following successful resuscitation from prolonged cer-
diacarrest. Successful treatment of post-resuscitation LVsystolic dysfunction
has been reported with Dobutamine (Debut). Dobutamine (10 @@rein)
was studied for ite effect on post-resuecitetion diastolic dysfunction in 14
swine. Eight additional swine were also studied as controls. Solid etate
micromanometer-tipped catheters were used for measurement of left ven-
tricular enddiastolic pressure, and the calculation of the time constant of
isovolumic relaxation (Tau). Contrast left ventriculograms were performed
to calculate left ventricular volumes. Each aniwal underwent a 15-minute
period of untreated ventricular fibrillation cardiac arrest followed by resus-
citation. Data were collected at a pre-arrest baseline and at 5-hours post
successful resuscitation. Table 1 shows the improved diastolic function at
5-hours post-resuscitation in the Dobutamine treated animals compared with
controls.
LVEDP LVEDV EDP/EDV Tau
(mmHg) (ml) (x 100) (msec)
Baseline
Controls 11 * 1 2S A 6 41 * 5 2s* 1
Debut. 11 * 1 31 l 2 38 k 4
5 Hours
31 l 1“
Controla 20+ 3 28+ 5 76* 11 41 * 3
Dobut. 9+ 1“ 25* 3 47 k 6’ 31 *5*
*ps 0.05 vs controls
Dobutamine (10 @kg/rein) can successfully overcome left ventricular
diastolic dysfunction seen 5 hrs. after successful resuscitation from cardiac
arrest.
